Publications Office of the EU
Competition enforcement in the pharmaceutical sector (2009-2017)
DisplayCustomHeader
MyPortal
lietuvių kalba
BasketSummary
Web turinio atvaizdavimas
Publication Detail Actions Portlet

Priemonės

Publication Detail Actions Portlet
 Naudotojų vertinimas
custom-survey-notification
Publication Detail Portlet

Publication detail

Home

Competition enforcement in the pharmaceutical sector (2009-2017)

European competition authorities working together for affordable and innovative medicines

Yra paskelbtas naujesnis šio leidinio leidimas

Leidinio metaduomenys

Following the European Commission’s inquiry into the pharmaceutical sector in 2009, competition law enforcement and market monitoring in this area have been a high priority across the EU. This report provides an overview of how the Commission and the national competition authorities of the 28 Member States (‘European competition authorities’) have enforced EU antitrust and merger rules in the pharmaceutical sector in 2009-2017. It responds to concerns expressed by the Council and the European Parliament that anti-competitive practices of pharmaceutical companies may endanger patients access to affordable and innovative essential medicines.
Rodyti daugiau
Rodyti mažiau
ISBN 978-92-79-98278-1
DOI 10.2763/218954
Katalogo numeris KD-07-18-081-EN-N
PDF
ISSN ISBN 978-92-79-98278-1 DOI 10.2763/218954 Katalogo numeris KD-07-18-081-EN-N
  • Released on EU publications website:
Publication Viewer

Dokumentų žiūryklė

Pop up window annotations